• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthmedicine

Joe Rogan’s highly questionable ivermectin COVID-19 ‘cure’ may be lethal. It’s also catching on around the world

Sophie Mellor
By
Sophie Mellor
Sophie Mellor
Down Arrow Button Icon
Sophie Mellor
By
Sophie Mellor
Sophie Mellor
Down Arrow Button Icon
September 2, 2021, 6:38 AM ET

Ivermectin is an antiparasitic pill mainly used to deworm horses and cows. It is also, according to podcast star Joe Rogan, a great way to treat COVID-19.

Even before the endorsement from Rogan, who recently came down with COVID-19 and treated it with a cocktail of drugs unproven to be effective against the illness, ivermectin had been growing in popularity. In places like Brazil, Bolivia, Peru, and South Africa—along with the U.S.—people were using it to self-medicate against COVID-19.

Google searches for ivermectin are at an all-time high. Searches for ivermectin jumped alongside other at-home remedies like “hydroxychloroquine” at the start of the pandemic in March 2020, but while the Trump-backed hydroxychloroquine fell out of favor, ivermectin maintained its popularity. Prescriptions for ivermectin jumped to more than 88,000 in the week ended Aug. 13, and some pharmacists have even reported shortages of the drug.

But as with many unproven medicines, it can have fatal consequences.

Calls to poison control centers about ivermectin exposures have risen fivefold over the baseline in July, according to CDC researchers who used data from the American Association of Poison Control Centers.

Mississippi’s health department even issued an alert in August saying 70% of recent calls to the state poison control center had come from people who over-ingested ivermectin from livestock supply stores.

Such dangerous effects from self-prescription have prompted Merck, the manufacturer of the drug, to come out and say there was no scientific basis for ivermectin to be used as treatment against COVID-19 and the Food and Drug Administration to caution against ingestion of the medicine, warning that “using the drug ivermectin to treat COVID-19 can be dangerous and even lethal.”

Beyond ivermectin’s potential dangers, the drug also appears to offer little benefit in the fight against COVID. Researchers looking into the efficacy of ivermectin as a COVID-19 treatment had to shut down a large 1,300 patient trial because the drug had been no better than a placebo at preventing hospitalizations. Dr. Edward Mills, a professor at McMaster University who led the study, noted the team would have discontinued it earlier were it not for the level of public interest in ivermectin.

Researchers and physicians are particularly worried by people who are seeking out ivermectin to prevent COVID-19 in lieu of getting a vaccine.

But this has not stopped Rogan, the popular podcast host who has already been in hot water for suggesting young, fit people don’t need to get the COVID-19 vaccine.

After announcing a few canceled tour dates owing to his illness, Rogan gave a shout-out to the medicine, saying “a wonderful, heartfelt thank you to modern medicine for pulling me out of this so quickly and so easily.”

https://www.instagram.com/p/CTSsA8wAR2-/

Instagram captioned his post with a short warning: “Some unapproved COVID-19 treatments may cause serious harm.”

Facebook, owner of Instagram, did not respond to requests for comment.

Subscribe to Fortune Daily to get essential business stories straight to your inbox each morning.
About the Author
Sophie Mellor
By Sophie Mellor
LinkedIn iconTwitter icon
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Most Popular

placeholder alt text
Commentary
Yes, you're getting a bigger tax refund. Your kids won't thank you for the $3 trillion it's adding to the deficit
By Daniel BunnJanuary 26, 2026
2 days ago
placeholder alt text
Personal Finance
Current price of silver as of Tuesday, January 27, 2026
By Joseph HostetlerJanuary 27, 2026
1 day ago
placeholder alt text
Success
Despite running $75 billion automaker General Motors, CEO Mary Barra still responds to ‘every single letter’ she gets by hand
By Preston ForeJanuary 26, 2026
2 days ago
placeholder alt text
Economy
An unusual Fed ‘rate check’ triggered a free fall in the U.S. dollar and investors are fleeing into gold
By Jim EdwardsJanuary 26, 2026
2 days ago
placeholder alt text
Personal Finance
Current price of silver as of Monday, January 26, 2026
By Joseph HostetlerJanuary 26, 2026
2 days ago
placeholder alt text
Success
As AI wipes out desk jobs, Citigroup CEO Jane Fraser says the company is training 175,000 employees to ‘reinvent themselves’ before their roles change forever
By Emma BurleighJanuary 27, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Latest in Health

succession
SuccessFamily
How not to say that thing you’ll regret forever: 3 rules for family conversations about money 
By Glenn KurlanderJanuary 28, 2026
3 hours ago
reem
Commentaryhunger
How to fight child hunger in a time of foreign aid cuts
By Reem Alabali Radovan, Rajiv J. Shah and Mads Krogsgaard ThomsenJanuary 28, 2026
7 hours ago
People walk outside of a WeWork office building in London.
Future of WorkOffice Culture
Amazon and JPMorgan led the Fortune 500 in returning to the office 5 days a week. Now they’re leading a coworking comeback
By Jacqueline MunisJanuary 27, 2026
20 hours ago
Healthbeauty
5 Best Red Light Therapy Panels of 2026: Personally Tested
By Christina SnyderJanuary 27, 2026
20 hours ago
Graphic reads: Fortune Titans and Disruptors of Industry with Albert Bourla, CEO of Pfizer, Hosted by Alyson Shontell (both pictured).
C-SuiteFortune 500: Titans and Disruptors of Industry
Pfizer CEO Albert Bourla stared down the COVID-19 pandemic. Now he has his eyes set on cancer 
By Fortune EditorsJanuary 27, 2026
1 day ago
Palantir CEO Alex Karp during an interview at the 2026 World Economic Forum in Davos, Switzerland.
InnovationImmigration
Palantir/ICE connections draw fire as questions raised about tool tracking Medicaid data to find people to arrest
By Tristan BoveJanuary 26, 2026
2 days ago